tradingkey.logo
tradingkey.logo
Buscar

Transmedics Group Inc

TMDX
Añadir a la lista de seguimiento
67.850USD
+1.430+2.15%
Cierre 07/01, 16:00ETCotizaciones retrasadas 15 min
2.34BCap. mercado
13.44P/E TTM

Más Datos de Transmedics Group Inc Compañía

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.

Información de Transmedics Group Inc

Símbolo de cotizaciónTMDX
Nombre de la empresaTransmedics Group Inc
Fecha de salida a bolsaMay 02, 2019
Director ejecutivoHassanein (Waleed H)
Número de empleados728
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 02
Dirección200 Minuteman Road
CiudadANDOVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01810
Teléfono19785520900
Sitio Webhttps://www.transmedics.com/
Símbolo de cotizaciónTMDX
Fecha de salida a bolsaMay 02, 2019
Director ejecutivoHassanein (Waleed H)

Ejecutivos de Transmedics Group Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
16.64K
+58.05%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
15.11K
+19.34%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
6.98K
+41.86%
Ms. Stephanie Lovell
Ms. Stephanie Lovell
Independent Director
Independent Director
5.79K
+50.48%
Mr. Gerardo Hernandez
Mr. Gerardo Hernandez
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
3.00K
+88.95%
Dr. Tamer I. Khayal, M.D.
Dr. Tamer I. Khayal, M.D.
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Edward M. Basile
Mr. Edward M. Basile
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Waleed H. Hassanein, M.D.
Dr. Waleed H. Hassanein, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
564.33K
+14.66%
Mr. James R. Tobin
Mr. James R. Tobin
Independent Chairman of the Board
Independent Chairman of the Board
188.13K
+1.55%
Mr. Thomas James Gunderson
Mr. Thomas James Gunderson
Independent Director
Independent Director
16.64K
+58.05%
Dr. David Weill, M.D.
Dr. David Weill, M.D.
Independent Director
Independent Director
15.11K
+19.34%
Mr. Nicholas (Nick) Corcoran
Mr. Nicholas (Nick) Corcoran
Senior Vice President - Supply Chain and Operations
Senior Vice President - Supply Chain and Operations
14.35K
+57.82%
Ms. Merilee Raines, CPA
Ms. Merilee Raines, CPA
Independent Director
Independent Director
6.98K
+41.86%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Transmedics Group Inc?

Los cinco principales accionistas de Transmedics Group Inc son: Dr. Waleed H. Hassanein, M.D.

¿Cuántas instituciones poseen acciones de Transmedics Group Inc (TMDX)?

A fecha de 2026Q1, 865 instituciones poseen acciones de Transmedics Group Inc, con un valor de mercado combinado de aproximadamente 42.29M, lo que representa el 122.36% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -1737478.00.

¿Cuál es la mayor fuente de ganancias de Transmedics Group Inc?

El 2026Q1, el segmento empresarial OCS Liver net revenue generó la ganancia más alta para Transmedics Group Inc, ascendiendo a 460.53M y representando el 76.58% de la ganancia total.